We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
Frank
Milligan
frank.milligan@beds.ac.uk
Prof
Alan
Sinclair
ajsinclair@diabetesfrail.org
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Adverse drug events (ADEs), such as drug prescribing and administration errors, dispensing problems and adverse drug reactions, are a common cause of patient safety incidents in health and social care settings. Diabetes is a common health problem in the UK affecting an estimated 2.6 million people and up to 26% of the nursing home population. The research question for this study is; “What are the ‘root causes’ of significant adverse drug events that residents with diabetes in the nursing home setting suffer and how can medicines management, with particular reference to NHS systems, be improved?”
Root Cause Analysis (RCA) is a research technique and investigative process that systematically examines a range of evidence relevant to an incident. This study will identify drug errors linked to NHS medicines management that have occurred in nursing homes and describe and then analyse those incidents to identify lessons and strategies to reduce the chances of them happening in the future.
Nursing homes within Bedfordshire and Hertfordshire will be asked to participate in the study. Those that agree will be asked to identify adverse drug events that have occurred in relation to diabetes medication, both oral and injected.
These individual descriptions of patient safety incidents will be summarised as short case narratives (stories). Each of these will be assessed in terms of level of harm to identify the 'moderate' to 'severe' risk incidents and 25 of these will then be subject to RCA review.
The RCA data across the sample of 25 cases will then be analysed together through a process called Qualitative Aggregation/Meta analysis in order to identify common and significant themes. Strategies to improve for medicines management between the NHS and nursing home sector will then be generated and disseminated.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
1. Nursing home residents who have suffered an adverse drug event that is subject to criminal investigation 2. Nursing home residents, or the lay carer of the resident involved in medicines management, who do not speak English. 3. Residents, lay carers/significant others or staff who do not consent to participate.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Bedfordshire and funded by NIHR Central Commissioning Facility (CCF) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 13610
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
